| Literature DB >> 3937758 |
M J Sheehy, J R Rowe, T C Fuller, E J Yunis, K H Gabbay.
Abstract
We have been using human T-lymphocyte clones specifically sensitized to detect leucocyte antigens of Type 1 (insulin-dependent) diabetic patients in the hope of detecting novel HLA antigens associated with Type 1 diabetes. We previously described two such clones which define a new class II HLA antigen, Boston-1 (BO1). BO1 is found mainly on cells of persons with particular HLA-DR antigens and, of potential significance for diabetes, BO1 identifies a distinctive subset of DR3 haplotypes. We report here that BO1+ DR3 haplotypes are overrepresented in Type 1 diabetes. That is, significantly more of the DR3-positive subjects are BO1-positive in the patient group (31%) than in the control group (8%), suggesting that a diabetes-susceptibility gene may be more common on the BO1+ than on the BO1- DR3 haplotypes. Alternative interpretations are also discussed.Entities:
Mesh:
Substances:
Year: 1985 PMID: 3937758 DOI: 10.1007/bf00703131
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122